Microcap Bullish Stocks: AVEO Pharmaceuticals (NASDAQ:AVEO), DragonWave, Inc.(USA) (NASDAQ:DRWI), Conatus Pharmaceuticals Inc (NASDAQ:CNAT), China Finance Online Co. (ADR) (NASDAQ:JRJC)

On May 31, 2014, AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), announced the presentation of results from a first-in-human Phase 1 study of AV-203, AVEO’s ErbB3 (HER3) inhibitory antibody candidate. Among the results, the study established a recommended Phase 2 dose of AV-203, demonstrated good tolerability and promising early signs of activity, and reached the maximum planned dose of AV-203 monotherapy. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), weekly performance is 20.39%. On last trading day company shares ended up $1.83. Analysts mean target price for the company is $1.67. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), distance from 50-day simple moving average (SMA50) is 45.96%.

On June 20, 2014, DragonWave, Inc.(USA) (NASDAQ:DRWI), a leading global supplier of packet microwave radio systems for mobile and access networks, announced that all of management’s nominees listed in the management proxy circular of DragonWave dated May 23, 2014 were elected as directors of DragonWave to hold office until the next annual meeting of shareholders of DragonWave or until their successors are elected or appointed. DragonWave, Inc.(USA) (NASDAQ:DRWI), advanced 8.81% in last trading session and ended the day on $2.10. DRWI, Gross Margin is 9.50% and its return on assets is -46.70%. DragonWave, Inc.(USA) (NASDAQ:DRWI), quarterly performance is 50.00 %.

Roth Capital assumed coverage on shares of Conatus Pharmaceuticals Inc (NASDAQ:CNAT), in a report issued on Friday,TheFlyOnTheWall.com reports. The firm issued a buy rating and a $19.00 target price on the stock. Conatus Pharmaceuticals Inc (NASDAQ:CNAT), shares moved up 8.71% in last trading session and was closed at $9.11, while trading in range of $8.06 – 9.33. Conatus Pharmaceuticals Inc (NASDAQ:CNAT), year to date (YTD) performance is 41.24%.

On June 12, 2014, China Finance Online Co. (ADR) (NASDAQ:JRJC), gained 9.15%, the company recently reported that it expects to report net revenues of $21.0 million for the 1st quarter of 2014, up 281.8% from $5.5 million in the 1st quarter of 2013. The expected net revenues reflect the impact of fewer trading days in the 1st quarter due to the long Chinese New Year holidays.China Finance Online Co. (ADR) (NASDAQ:JRJC), ended the last trading day at $4.17. Company weekly volatility is calculated as 9.64% and price to cash ratio as 2.55. China Finance Online Co. (ADR) (NASDAQ:JRJC), showed a negative weekly performance of 14.84%.